MindWalk joins Russell 3000E ahead of Q4FY26 results on July 22
MindWalk Holdings Corp. will report Q4 and FY26 results on July 22, 2026, following its inclusion in the Russell 3000E Index and a European patent filing for its HYFT Technology.

*this image is generated using AI for illustrative purposes only.
MindWalk Holdings Corp. will report financial results for the fourth quarter and full fiscal year 2026 on July 22, 2026, following its recent addition to the Russell 3000E Index. The company, a Bio-Native AI firm listed on NASDAQ under the ticker HYFT, will release the results via press release prior to a scheduled conference call. The announcement will provide insights into the company's performance and recent business developments for the period, including its progress in GLP-1 metabolic health and infectious disease programs.
Conference Call Details
The earnings conference call is scheduled for Wednesday, July 22, 2026, at 5:00 p.m. Eastern Time. Management will present the financial results followed by a question-and-answer session. Investors and interested parties can access the live webcast and replay through the Events section of the company's Investor Relations pages.
Participation Information
Participants can join the call using the following dial-in numbers:
| Region | Dial-In Number |
|---|---|
| USA / International Toll | +1 (646) 307-1963 |
| USA Toll-Free | (800) 715-9871 |
| Canada (Toronto) | (647) 932-3411 |
| Canada Toll-Free | (800) 715-9871 |
Strategic Developments
MindWalk was added to the Russell 3000E Index effective after the U.S. market close on June 26, 2026, broadening its eligibility for index-tracking funds. The company also filed a European patent application covering the high-dimensional data architecture behind its proprietary HYFT Technology and ReefIQ biological context layer. For the second quarter of fiscal 2026, the company reported revenue of approximately US$3.0 million, up 54% year over year, and gross profit up 94%. It divested non-core wet-lab operations in the Netherlands for approximately US$11.7 million in net proceeds to sharpen its focus on its AI platform.
About MindWalk Holdings Corp.
MindWalk Holdings Corp. focuses on building BioIntelligence infrastructure for life sciences AI and agentic AI. The company integrates AI, data, and advanced wet lab capabilities into a connected discovery ecosystem. Its core technology, HYFT, is a proprietary, function-aware representation of biology that spans sequence and structural biology. This technology supports products such as ReefIQ, a biological data substrate, and LensAI, a reasoning and application layer for target discovery and portfolio decision support.
How will inclusion in the Russell 3000E Index impact MindWalk's liquidity and institutional investor base over the next year?
What specific milestones does the company aim to achieve in its GLP-1 metabolic health and infectious disease programs by the end of fiscal 2026?
How does MindWalk plan to allocate the $11.7 million in net proceeds from the divestiture of its wet-lab operations to scale its AI platform?





























